159 related articles for article (PubMed ID: 37573525)
1. Toxic effects of AB-CHMINACA on liver and kidney and detection of its blood level in adult male mice.
Mohammad SA; Mousa REA; Gebril SM; Masoud KMM; Radwan RA
Forensic Toxicol; 2024 Jan; 42(1):7-17. PubMed ID: 37573525
[TBL] [Abstract][Full Text] [Related]
2. Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA.
Hermanns-Clausen M; Müller D; Kithinji J; Angerer V; Franz F; Eyer F; Neurath H; Liebetrau G; Auwärter V
Clin Toxicol (Phila); 2018 Jun; 56(6):404-411. PubMed ID: 29072524
[TBL] [Abstract][Full Text] [Related]
3. Determination of AB-CHMINACA and its metabolites in human hair and their deposition in hair of abusers.
Sim J; Cho HS; Lee J; In S; Kim E
J Pharm Biomed Anal; 2017 Jun; 140():162-168. PubMed ID: 28359963
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo human metabolism of the synthetic cannabinoid AB-CHMINACA.
Erratico C; Negreira N; Norouzizadeh H; Covaci A; Neels H; Maudens K; van Nuijs AL
Drug Test Anal; 2015 Oct; 7(10):866-76. PubMed ID: 25865117
[TBL] [Abstract][Full Text] [Related]
5. Aspects related to analysis and medico-legal assessment in the context of the presence of synthetic cannabinoids in biological material based on the example of AB-CHMINACA.
Romańczuk A; Rojek S; Kula K; Kłys M
Arch Med Sadowej Kryminol; 2018; 68(4):266-280. PubMed ID: 31025844
[TBL] [Abstract][Full Text] [Related]
6. Three fatalities associated with the synthetic cannabinoids 5F-ADB, 5F-PB-22, and AB-CHMINACA.
Angerer V; Jacobi S; Franz F; Auwärter V; Pietsch J
Forensic Sci Int; 2017 Dec; 281():e9-e15. PubMed ID: 29133010
[TBL] [Abstract][Full Text] [Related]
7. AB-CHMINACA-induced sudden death from non-cardiogenic pulmonary edema.
Maeda H; Kikura-Hanajiri R; Kawamura M; Nagashima E; Yoshida KI
Clin Toxicol (Phila); 2018 Feb; 56(2):143-145. PubMed ID: 28707493
[TBL] [Abstract][Full Text] [Related]
8. Identification and quantification of metabolites of AB-CHMINACA in a urine specimen of an abuser.
Wurita A; Hasegawa K; Minakata K; Gonmori K; Nozawa H; Yamagishi I; Suzuki O; Watanabe K
Leg Med (Tokyo); 2016 Mar; 19():113-8. PubMed ID: 26257317
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of an indazole-3-carboxamide class synthetic cannabinoid: 2-[1-(cyclohexylmethyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoic acid (DMBA-CHMINACA).
Lee JH; Jung A; Park HN; Lee C; Mandava S; Lim SJ; Lim BB; Park SK; Lee J; Kang H
Forensic Sci Int; 2018 Oct; 291():167-174. PubMed ID: 30216842
[TBL] [Abstract][Full Text] [Related]
10. The 2-alkyl-2
Longworth M; Banister SD; Mack JBC; Glass M; Connor M; Kassiou M
Forensic Toxicol; 2016; 34():286-303. PubMed ID: 27547266
[TBL] [Abstract][Full Text] [Related]
11. Concentrations of AB-CHMINACA and AB-PINACA and Driving Behavior in Suspected Impaired Driving Cases.
Peterson BL; Couper FJ
J Anal Toxicol; 2015 Oct; 39(8):642-7. PubMed ID: 26378139
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the pharmacological properties of JWH-122 isomers and THJ-2201, RCS-4 and AB-CHMINACA in HEK293T cells and hippocampal neurons.
Costain WJ; Rasquinha I; Comas T; Hewitt M; Aylsworth A; Rouleau Y; Marleau V; Soo EC; Tauskela JS
Eur J Pharmacol; 2018 Mar; 823():96-104. PubMed ID: 29408093
[TBL] [Abstract][Full Text] [Related]
13. Identification and quantification of predominant metabolites of synthetic cannabinoid MAB-CHMINACA in an authentic human urine specimen.
Hasegawa K; Minakata K; Gonmori K; Nozawa H; Yamagishi I; Watanabe K; Suzuki O
Drug Test Anal; 2018 Feb; 10(2):365-371. PubMed ID: 28560823
[TBL] [Abstract][Full Text] [Related]
14. AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in Mice.
Wiley JL; Marusich JA; Lefever TW; Antonazzo KR; Wallgren MT; Cortes RA; Patel PR; Grabenauer M; Moore KN; Thomas BF
J Pharmacol Exp Ther; 2015 Sep; 354(3):328-39. PubMed ID: 26105953
[TBL] [Abstract][Full Text] [Related]
15. In vitro Phase I metabolism of indazole carboxamide synthetic cannabinoid MDMB-CHMINACA via human liver microsome incubation and high-resolution mass spectrometry.
Presley BC; Logan BK; Jansen-Varnum SA
Drug Test Anal; 2019 Aug; 11(8):1264-1276. PubMed ID: 31108568
[TBL] [Abstract][Full Text] [Related]
16. Functional effects of synthetic cannabinoids versus Δ
Schreiber S; Bader M; Lenchinski T; Meningher I; Rubovitch V; Katz Y; Cohen E; Gabet Y; Rotenberg M; Wolf EU; Pick CG
Addict Biol; 2019 May; 24(3):414-425. PubMed ID: 29423994
[TBL] [Abstract][Full Text] [Related]
17. Analyte protectant approach to protect amide-based synthetic cannabinoids from degradation and esterification during GC-MS analysis.
Mohamed Masoud KM; Syed SM; Alasiri AM
J Chromatogr A; 2024 Jun; 1730():465022. PubMed ID: 38861824
[TBL] [Abstract][Full Text] [Related]
18. Cannabimimetic effects of abused indazole-carboxamide synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA and 5F-ADB-PINACA in mice: Tolerance, dependence and withdrawal.
Wilson CD; Hiranita T; Fantegrossi WE
Drug Alcohol Depend; 2022 Jul; 236():109468. PubMed ID: 35643039
[TBL] [Abstract][Full Text] [Related]
19. Do you feel it now? Route of administration and Δ
Wiley JL; Lefever TW; Glass M; Thomas BF
Neurotoxicology; 2019 Jul; 73():161-167. PubMed ID: 30953678
[TBL] [Abstract][Full Text] [Related]
20. Rapid Identification of MDMB-CHMINACA Metabolites Using Zebrafish and Human Liver Microsomes as the Biotransformation System by LC-QE-HF-MS.
Xu DQ; Dai Y; Zhang WF; Wang JF; Wang YY; Zhang Y; Zhao QL; Li X
J Anal Toxicol; 2021 Jan; 44(9):1012-1026. PubMed ID: 32020177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
